Interstitial Cystitis Pelvic Floor Physical and Occupational Therapy BPC 157 is back in the conversation as a potential peptide to improve musculoskeletal tissue repair. One registered Phase 1 trial in healthy volunteers exists for an oral formulation (NCT02637284) Brandon Roberts Peptide Therapy in Brandon & Lakeland, FL BPC 157, TB 500 & GHK Cu Urine biomarkers in ESSIC type 2 interstitial cystitis bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm Scientific Reports Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle to Bone Reattachment in Rats Frontiers Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats